Annals of Surgical Oncology

, Volume 20, Issue 13, pp 4200–4204 | Cite as

Minimal Benefit to Subsequent Intraoperative Parathyroid Hormone Testing After All Four Glands Have Been Identified

  • Kamal Ahmed
  • Amal Alhefdhi
  • David F. Schneider
  • Kristin A. Ojomo
  • Rebecca S. Sippel
  • Herbert Chen
  • Haggi Mazeh
Endocrine Tumors



Modern tools, such as intraoperative parathyroid hormone (IoPTH) assay, reduce operative time and extent of parathyroidectomy. However, the utility of a subsequent final set of IoPTH after all four glands are visualized remains questionable. This study was designed to determine the added value of IoPTH assay following parathyroidectomy with four-gland visualization in patients with primary hyperparathyroidism (PHPT).


A retrospective review of patients who underwent parathyroidectomy for PHPT between July 2001 and February 2012 by two experienced endocrine surgeons was performed. Included were patients with operative reports indicating that all four parathyroid glands were identified. Following four-gland visualization a subsequent final set of IoPTH was measured to confirm cure. Cure was defined as at least 50 % fall by 5, 10, or 15 min postexcision compared with preincision levels.


Of 1,838 patients that underwent parathyroidectomy, four glands were visualized in 238 cases (13 %). Of those patients meeting inclusion criteria with four glands visualized, the final set of IoPTH fell to cure criteria in 235 patients (98 %). An inadequate drop was documented in three (2 %) patients all of which were found to have multigland disease. Only in one patient (0.4 %) was a fifth parathyroid gland identified and resected. In all three cases, the subsequent final IoPTH did not affect the ultimate outcome or cure rate.


When experienced surgeons visualize all four parathyroid glands, drawing a subsequent final set of IoPTH rarely changes the operative course and therefore serves a limited role.


Parathyroid Gland Minimally Invasive Parathyroidectomy Bilateral Neck Exploration IoPTH Level Double Adenoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors have no disclosures or financial conflicts of interest.


  1. 1.
    Adler JT, Sippel RS, Chen H. New trends in parathyroid surgery. Curr Probl Surg. 2010;47:958–1017.PubMedCrossRefGoogle Scholar
  2. 2.
    Mazeh H, Sippel RS, Chen H. The role of gender in primary hyperparathyroidism: same disease, different presentation. Ann Surg Oncol. 2012;19:2958–62.Google Scholar
  3. 3.
    Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–70; discussion 70–2.PubMedCrossRefGoogle Scholar
  4. 4.
    Lew JI, Solorzano CC. Surgical management of primary hyperparathyroidism: state of the art. Surg Clin N Am. 2009;89:1205–25.PubMedCrossRefGoogle Scholar
  5. 5.
    Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8; discussion 8–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin N Am. 2004;84:717–34.PubMedCrossRefGoogle Scholar
  8. 8.
    Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery. 1999;126:1016–21; discussion 21–2.PubMedCrossRefGoogle Scholar
  9. 9.
    Gracie D, Hussain SS. Use of minimally invasive parathyroidectomy techniques in sporadic primary hyperparathyroidism: systematic review. J Laryngol Otol. 2012;126:221–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee JA, Inabnet III WB. The surgeon’s armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol. 2005;89:130–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Irvin III GL, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg. 1991;162:299–302.PubMedCrossRefGoogle Scholar
  12. 12.
    Irvin III GL, American Association of Endocrine Surgeons. Presidential address: chasin’ hormones. Surgery. 1999;126:993–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012;214:260–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases. Surgery. 2012;152:1008–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7; discussion 7–90.PubMedCrossRefGoogle Scholar
  16. 16.
    Moor JW, Roberts S, Atkin SL, England RJ. Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck. 2011;33:293–6.PubMedGoogle Scholar
  17. 17.
    Pitt SC, Panneerselvan R, Chen H, Sippel RS. Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg. 2010;34:1343–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Gasparri G, Camandona M, Bertoldo U, et al. The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Ann Surg. 2009;250:868–71.PubMedCrossRefGoogle Scholar
  19. 19.
    Conzo G, Perna A, Avenia N, et al. Evaluation of the ‘putative’ role of intraoperative intact parathyroid hormone assay during parathyroidectomy for secondary hyperparathyroidism. A retrospective study on 35 consecutive patients: intraoperative iPTH assay during parathyroidectomy. Endocrine. 2012;42:606–11.PubMedCrossRefGoogle Scholar
  20. 20.
    Smith N, Magnuson JS, Vidrine DM, Kulbersh B, Peters GE. Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies. Arch Otolaryngol Head Neck Surg. 2009;135:1108–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Schneider R, Waldmann J, Ramaswamy A, Fernandez ED, Bartsch DK, Schlosser K. Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg. 2011;35:1260–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Welch K, McHenry CR. The role of transcervical thymectomy in patients with hyperparathyroidism. Am J Surg. 2012;203:292–5; discussion 5–6.PubMedCrossRefGoogle Scholar
  23. 23.
    d’Alessandro AF, Montenegro FL, Brandao LG, Lourenco Jr DM, Toledo Sde A, Cordeiro AC. Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1. Rev Assoc Med Bras. 2012;58:323–7.PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2013

Authors and Affiliations

  • Kamal Ahmed
    • 1
  • Amal Alhefdhi
    • 1
  • David F. Schneider
    • 1
  • Kristin A. Ojomo
    • 1
  • Rebecca S. Sippel
    • 1
  • Herbert Chen
    • 1
  • Haggi Mazeh
    • 1
    • 2
  1. 1.Section of Endocrine Surgery, Department of SurgeryUniversity of WisconsinMadisonUSA
  2. 2.Department of SurgeryHadassah-Hebrew University Medical CenterJerusalemIsrael

Personalised recommendations